Lepu Medical Technology Secures China's Nod for Weight Control Drug Trial
Lepu Medical Technology Beijing (SHE:300003) received China's regulatory approval to begin clinical trials for MWN110 injection for weight control in adults, according to a Wednesday filing with the Shenzhen bourse.Shares of the medical device and pharmaceutical company closed 1% higher Thursday.